Vaughan Nelson Investment Management L.P. increased its stake in Rxo Inc (NYSE:RXO - Free Report) by 15.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,730,665 shares of the company's stock after purchasing an additional 355,255 shares during the quarter. Vaughan Nelson Investment Management L.P. owned 1.67% of RXO worth $52,155,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in RXO. SG Americas Securities LLC lifted its position in shares of RXO by 251.2% during the 1st quarter. SG Americas Securities LLC now owns 51,761 shares of the company's stock valued at $989,000 after acquiring an additional 37,024 shares during the period. Thurston Springer Miller Herd & Titak Inc. increased its stake in RXO by 52.5% in the 1st quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,745 shares of the company's stock valued at $52,000 after purchasing an additional 945 shares in the last quarter. Douglas Lane & Associates LLC raised its holdings in RXO by 34.3% during the first quarter. Douglas Lane & Associates LLC now owns 3,591,040 shares of the company's stock worth $68,589,000 after purchasing an additional 916,379 shares during the last quarter. Rhumbline Advisers grew its holdings in RXO by 1.1% in the first quarter. Rhumbline Advisers now owns 413,204 shares of the company's stock valued at $7,892,000 after purchasing an additional 4,337 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in RXO by 1,728.8% in the first quarter. GAMMA Investing LLC now owns 36,997 shares of the company's stock valued at $707,000 after purchasing an additional 34,974 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company's stock.
Wall Street Analyst Weigh In
RXO has been the subject of several recent research reports. Citigroup restated a "neutral" rating and set a $18.00 target price (up from $15.00) on shares of RXO in a report on Wednesday, May 21st. Barclays cut their price objective on RXO from $24.00 to $22.00 and set an "overweight" rating for the company in a research report on Wednesday, April 2nd. Deutsche Bank Aktiengesellschaft assumed coverage on RXO in a report on Friday, March 7th. They set a "hold" rating and a $19.00 target price on the stock. Susquehanna cut their target price on shares of RXO from $18.00 to $13.00 and set a "negative" rating for the company in a research note on Wednesday, March 26th. Finally, UBS Group reduced their target price on shares of RXO from $24.00 to $14.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $20.00.
Check Out Our Latest Report on RXO
RXO Trading Up 2.7%
RXO stock traded up $0.41 on Wednesday, hitting $15.52. 951,074 shares of the company were exchanged, compared to its average volume of 1,310,013. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.30 and a quick ratio of 1.30. The stock has a market capitalization of $2.54 billion, a price-to-earnings ratio of -7.14, a price-to-earnings-growth ratio of 6.56 and a beta of 1.73. Rxo Inc has a twelve month low of $12.19 and a twelve month high of $32.82. The business's fifty day moving average is $14.93 and its two-hundred day moving average is $19.87.
RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.01). The firm had revenue of $1.43 billion for the quarter, compared to analysts' expectations of $1.51 billion. RXO had a negative net margin of 5.94% and a positive return on equity of 1.18%. RXO's revenue was up 57.0% on a year-over-year basis. During the same period last year, the firm posted ($0.03) EPS. As a group, research analysts forecast that Rxo Inc will post 0.31 earnings per share for the current year.
RXO Company Profile
(
Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More

Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.